評論
打印
A drug being tested for several types of cancer treatment has been found to be effective at reversing drug resistance in head and neck skin cancers.
針對幾種類型的癌癥治療藥物測試發現，有一種藥物能夠有效扭轉頭頸部癌癥和皮膚癌癥的抗藥性。
Researchers at the University of Queensland in Australia found a specific protein was controlling drug resistance in the affected cells.
澳大利亞昆士蘭大學的研究人員發現在受影響的細胞中有一種特殊蛋白質可能控制抗藥性。
According to UPI, an estimated 13,740 people -- 10,250 men and 3,490 women -- will die from head and neck cancers this year,
合眾國際社消息稱，預計今年將有13,740人（10,250名男性以及3,490名女性）死于頭頸部癌癥，
with the two most significant risk factors for the diseases being alcohol and tobacco use.
而頭頸部癌最顯著的患病風險因素分別是酒精和煙草使用。
譯文屬可可英語原創，未經允許，不得轉載。
